Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues.
breast cancer
breast carcinoma
breast neuroendocrine neoplasms
neuroendocrine
review
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2020
2020
Historique:
received:
25
09
2020
accepted:
08
12
2020
entrez:
15
2
2021
pubmed:
16
2
2021
medline:
27
5
2021
Statut:
epublish
Résumé
Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1% of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment, our knowledge is still really uncertain. In the present short review of the medical literature on this topic, we have evaluated in details their epidemiology, risk factors, pathogenesis, pathology, clinical presentation, radiographic aspects, prognosis, and therapy. We have thus been able to identify a number of open issues regarding primary neuroendocrine neoplasms of the breast that need to be clarified. Our ultimate aim was actually to try to understand whether neuroendocrine neoplasms of the breast can be considered a definite clinical entity and if neuroendocrine differentiation of breast tumors has a really clinical relevance.
Identifiants
pubmed: 33584543
doi: 10.3389/fendo.2020.610230
pmc: PMC7874233
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
610230Informations de copyright
Copyright © 2021 Gallo, Campione, Di Vito, Fortunati, Lo Calzo, Messina, Ruggeri, Faggiano and Colao.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Breast Cancer. 2012 Aug;12(4):300-3
pubmed: 22513033
Med Oncol. 2012 Dec;29(4):2613-8
pubmed: 22467078
Hum Pathol. 2001 Jul;32(7):753-7
pubmed: 11486176
Pathology. 2021 Feb;53(2):170-178
pubmed: 32951906
Radiol Case Rep. 2017 Jan 05;12(1):1-12
pubmed: 28228868
Neoplasma. 2013;60(2):215-22
pubmed: 23259792
J Pathol. 2008 Oct;216(2):141-50
pubmed: 18720457
Cancer. 2010 Oct 1;116(19):4463-73
pubmed: 20572042
Case Rep Pathol. 2016;2016:6762085
pubmed: 27840759
Histopathology. 2002 Mar;40(3):211-4
pubmed: 11895485
Oncologist. 2016 Jan;21(1):28-32
pubmed: 26659223
Ann Surg Oncol. 2001 Apr;8(3):227-33
pubmed: 11314939
Breast Care (Basel). 2012 Oct;7(5):408-10
pubmed: 24647781
Oncologist. 2020 Sep;25(9):e1318-e1329
pubmed: 32472950
Neoplasia. 2017 Dec;19(12):991-1002
pubmed: 29091800
J Clin Oncol. 2006 Jun 20;24(18):2694-6
pubmed: 16702578
Ann Diagn Pathol. 2018 Jun;34:122-130
pubmed: 29661717
Breast Cancer Res Treat. 2010 Nov;124(2):413-7
pubmed: 20872069
Histopathology. 2016 Feb;68(3):422-32
pubmed: 26114478
Clin Imaging. 2014 Sep-Oct;38(5):734-8
pubmed: 25052497
Bull Cancer. 2018 Apr;105(4):431-439
pubmed: 29567279
Am J Pathol. 1985 Aug;120(2):186-92
pubmed: 4025508
Mod Pathol. 2018 Jan;31(1):68-82
pubmed: 28884749
Int J Surg Case Rep. 2017;38:29-31
pubmed: 28734185
Pathologe. 2019 Dec;40(Suppl 3):325-330
pubmed: 31781853
Chin J Cancer. 2012 Nov;31(11):549-56
pubmed: 22640624
J Mol Endocrinol. 2016 Nov;57(4):R153-R165
pubmed: 27658959
World J Surg. 2005 Jan;29(1):92-101
pubmed: 15599742
Endocr Pathol. 2020 Dec;31(4):321-329
pubmed: 32613538
Breast. 2014 Apr;23(2):120-7
pubmed: 24342375
Korean J Radiol. 2013 May-Jun;14(3):395-9
pubmed: 23690703
Breast J. 2020 Mar;26(3):505-507
pubmed: 31513314
Virchows Arch. 2020 Oct 6;:
pubmed: 33025295
Eur Radiol. 2003 Apr;13(4):788-93
pubmed: 12664118
World J Surg Oncol. 2013 Jun 05;11:128
pubmed: 23734899
Int J Biol Sci. 2017 Nov 1;13(11):1387-1397
pubmed: 29209143
Breast Cancer. 2007;14(2):250-3
pubmed: 17485914
Med Oncol. 2020 Jul 25;37(8):70
pubmed: 32712767
Arch Pathol Lab Med. 2017 Nov;141(11):1577-1581
pubmed: 29072945
J Med Case Rep. 2020 Mar 10;14(1):41
pubmed: 32156307
Int J Clin Exp Pathol. 2010 Jun 30;3(6):629-33
pubmed: 20661411
Chin J Cancer. 2017 May 11;36(1):45
pubmed: 28490384
Int J Clin Exp Pathol. 2020 Jun 01;13(6):1457-1462
pubmed: 32661484
BMC Cancer. 2014 Mar 04;14:147
pubmed: 24589259
J Clin Pathol. 2016 Jul;69(7):563-74
pubmed: 26915369
Case Rep Oncol. 2019 Feb 28;12(1):205-210
pubmed: 31011317
Nat Rev Clin Oncol. 2011 Aug 02;8(11):669-76
pubmed: 21808267
Cancers (Basel). 2020 Mar 20;12(3):
pubmed: 32244940
Oncol Rep. 2008 Dec;20(6):1369-74
pubmed: 19020716
Br Med J. 1975 Oct 25;4(5990):197-9
pubmed: 1191996
Int J Surg. 2008;6 Suppl 1:S113-5
pubmed: 19167937
Ann Oncol. 2001;12 Suppl 2:S115-7
pubmed: 11762336
Oncol Lett. 2011 Sep 1;2(5):887-890
pubmed: 22866145
Am J Case Rep. 2020 Oct 17;21:e925895
pubmed: 33067411
Pharmacol Ther. 2017 Nov;179:111-126
pubmed: 28549597
Endocr Pathol. 2017 Jun;28(2):121-127
pubmed: 28389994
Radiat Med. 2008 Jan;26(1):28-32
pubmed: 18236131
Breast Care (Basel). 2015 Aug;10(4):281-3
pubmed: 26600766
Endocr Pathol. 2014 Jun;25(2):141-50
pubmed: 24729037
Histopathology. 2002 Mar;40(3):215-22
pubmed: 11895486
Breast Care (Basel). 2016 Dec;11(6):424-426
pubmed: 28228710